InsidersTradesSigma
Track the Corbus Pharmaceuticals Holdings, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Corbus Pharmaceuticals Holdings, Inc. has logged 73 public disclosures. Market capitalisation: €2.3bn. The latest transaction was filed on 17 August 2026 (Attribution). Among the most active insiders: Cohen Yuval. The full history is accessible without an account.
73
Insider Decl.
n/a
Thresholds
€16m
13 ops.
Buy Volume
€925,593
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Corbus Pharmaceuticals Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$61.47.
47Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
Declarations73 total
58,333 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-354145:0
2,600 shares@ US$9.62940.0011% mcap100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-346966:0
Canonical exit: 9 Nov 2026 (T+90)
17,000 shares@ US$10.08210.0079% mcap23.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-342485:0
12,000 shares@ US$10.08090.0056% mcap33.4% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-342479:0
17,000 shares@ US$10.08210.0077% mcap58.6% of flowCommon StockSEC144:0001972481-26-000254
12,000 shares@ US$10.08090.0054% mcap41.4% of flowCommon StockSEC144:0001972481-26-000255
23,025 shares@ US$9.19950.011% mcap63.7% of flowCommon StockSEC144:0001972481-26-000237
2,412 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267655:0
4,800 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267671:0
2,026 sharesCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267672:0
58,300 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-237103:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234851:0
7,500 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234813:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234853:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234857:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234860:0
6,097 shares@ US$8.299440.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-091647:0
847 shares@ US$7.38324.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057174:0
4,701 shares@ US$7.78314.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057168:0
13,871 shares@ US$7.782619.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057159:0
3,285 shares@ US$8.089821.3% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-037647:0
2,415 shares@ US$8.089975.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-037643:0
28,365 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-015430:0
28,365 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-015429:0
25 of 73 declarations
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing treatments for inflammatory and fibrotic diseases. It is listed on NASDAQ under the ticker CRBP.